![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Yang Kun
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.30, Iss.4, 2010-04, pp. : 229-241
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Hawkins Neil Scott David A. Thatcher Nicholas
Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab in Non-Small Cell Lung Cancer
Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)